21% sales growth for Boston Scientific:
This article was originally published in Clinica
Executive Summary
Boston Scientific's total sales rose 21% to $1.9 billion in the year ended December 31. Excluding exchange rate effects, this represents an increase of 26%. In the fourth quarter, sales were $493 million, a 14% increase, or 19% excluding exchange rate effects. The US company will announce its full annual results in February.